ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Long Term Clinical Outcome of Liver Transplant Recipients Who Successfully Withdrawn Immunosuppression, The

T. Manzia, R. Angelico, L. Toti, L. Fazzolari, L. Tariciotti, D. Sforza, M. Manuelli, V. Tognoni, A. Di Giorgio, G. Tisone

UOC Chirurgia dei Trapianti, Tor Vergata University, Rome, Italy

Meeting: 2013 American Transplant Congress

Abstract number: D1726

Background. Clinical operational tolerance was defined as stable normal graft function in the total absence immunosuppression (IS). It may be achieved in up to 20% of liver transplant (LT) recipients. In this observational prospective study we report the outcome of long-term sustained IS avoidance after LT.

Methods. Twenty-two LT recipients (mean age: 68±5.8 years, M/F: 17/5) transplanted at our institution were completely withdrawn from IS. At weaning start, the median follow up from LT was 126±43.9 months. Nine recipients (40.9%) were withdrawn from mycophenolate mofetil and 13 (59%) from calcineurin inhibitors. The median time of weaning process was 7±3.4 months. Liver function tests, renal and metabolic parameters were compared before and after weaning. Evolution and/or new onset of comorbidities were also evaluated during the study period.

Results. The median follow-up of IS weaning was 64±43 months. All patients were alive and in good clinical status. None experienced graft rejection. No difference in terms of liver function (p=0.71), renal function (p=0.82) and lipid profile (p=0.29) were observed over the follow up period. None experienced comorbidities.

Conclusion. IS withdrawal once established seems to be durable and safe for the LT recipients.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Manzia T, Angelico R, Toti L, Fazzolari L, Tariciotti L, Sforza D, Manuelli M, Tognoni V, Giorgio ADi, Tisone G. Long Term Clinical Outcome of Liver Transplant Recipients Who Successfully Withdrawn Immunosuppression, The [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/long-term-clinical-outcome-of-liver-transplant-recipients-who-successfully-withdrawn-immunosuppression-the/. Accessed May 17, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences